000 | 01757 a2200457 4500 | ||
---|---|---|---|
005 | 20250517035636.0 | ||
264 | 0 | _c20160330 | |
008 | 201603s 0 0 eng d | ||
022 | _a1899-1505 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrzeda, E | |
245 | 0 | 0 |
_aBi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus. _h[electronic resource] |
260 |
_bJournal of physiology and pharmacology : an official journal of the Polish Physiological Society _cJun 2015 |
||
300 |
_a343-53 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmidohydrolases _xmetabolism |
650 | 0 | 4 | _aAnesthesia |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArachidonic Acids _xmetabolism |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCannabinoids _xpharmacology |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 |
_aCyclohexanols _xpharmacology |
650 | 0 | 4 |
_aEndocannabinoids _xmetabolism |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicroinjections |
650 | 0 | 4 |
_aMorpholines _xpharmacology |
650 | 0 | 4 |
_aParaventricular Hypothalamic Nucleus _xdrug effects |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aPolyunsaturated Alkamides _xmetabolism |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xantagonists & inhibitors |
700 | 1 | _aSchlicker, E | |
700 | 1 | _aLuczaj, W | |
700 | 1 | _aHarasim, E | |
700 | 1 | _aBaranowska-Kuczko, M | |
700 | 1 | _aMalinowska, B | |
773 | 0 |
_tJournal of physiology and pharmacology : an official journal of the Polish Physiological Society _gvol. 66 _gno. 3 _gp. 343-53 |
|
999 |
_c24991382 _d24991382 |